ATM/MAPK7 crosstalk in cancer

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Yélamos López, Joséca
• dc.date.accessioned 2018-02-08T07:59:52Z
• dc.date.available 2018-02-08T07:59:52Z
• dc.date.issued 2017
• dc.format.mimetype application/pdf
• dc.identifier.citation Yelamos J. ATM/MAPK7 crosstalk in cancer. Oncotarget. 2017 Feb 28;8(9):14271-14272. DOI : 10.18632/oncotarget.15367
• dc.identifier.doi http://dx.doi.org/10.18632/oncotarget.15367
• dc.identifier.issn 1949-2553
• dc.identifier.uri http://hdl.handle.net/10230/33829
• dc.language.iso eng
• dc.publisher Impact Journalsca
• dc.relation.ispartof Oncotarget. 2017 Feb 28;8(9):14271-2
• dc.rights Copyright : © 2017 Yélamos. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.subject.keyword ATM
• dc.subject.keyword DNA damage response
• dc.subject.keyword MAPK7
• dc.subject.other Càncer -- Aspectes genètics
• dc.title ATM/MAPK7 crosstalk in cancerca
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion